First report of colistin-resistant KPC-2 producingST258-Klebsiella pneumoniae in Spain
Valentín-Martín, Amparo; Bosque-Vall , Montserrat; Valverde-De Francisco, Aránzazu; Cantón-Moreno, Rafael.
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 31(7): 489-491, ago.-sept. 2013. tab
Artículo en Inglés | IBECS (España) | ID: ibc-114831
Documentos relacionados
An Intra-Hospital Spread of Colistin-Resistant <i>K. pneumoniae</i> Isolates-Epidemiological, Clinical, and Genetic Analysis.
Evolution of Colistin Resistance in the Klebsiella pneumoniae Complex Follows Multiple Evolutionary Trajectories with Variable Effects on Fitness and Virulence Characteristics.
Colistin-resistant Klebsiella pneumoniae bloodstream infection: old drug, bad bug.
Sequential Time-Kill, a Simple Experimental Trick To Discriminate between Pharmacokinetics/Pharmacodynamics Models with Distinct Heterogeneous Subpopulations versus Homogenous Population with Adaptive Resistance.
Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis.
Synergistic effect of tryptamine-urea derivatives to overcome the chromosomally-mediated colistin resistance in Klebsiella pneumoniae.
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches.
Roles of crrAB two-component regulatory system in Klebsiella pneumoniae: growth yield, survival in initial colistin treatment stage, and virulence.
Colistin resistance mutations in phoQ can sensitize Klebsiella pneumoniae to IgM-mediated complement killing.
Nanoemulsion of cinnamon oil to combat colistin-resistant Klebsiella pneumoniae and cancer cells.